Johan F Vansteenkiste Selected Research

Johan F Vansteenkiste Research Topics

Disease

17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2005
17	Neoplasms (Cancer) 01/2022 - 07/2002
8	Lung Neoplasms (Lung Cancer) 11/2018 - 02/2004
5	Disease Progression 01/2022 - 11/2018
4	Exanthema (Rash) 01/2022 - 03/2011
3	Anemia 03/2011 - 04/2008
2	Diarrhea 01/2022 - 03/2011
2	Nausea 11/2018 - 03/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 05/2008
2	Neutropenia 10/2015 - 01/2012
1	Colitis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Dermatitis 01/2022
1	Hyperphosphatemia 01/2020
1	Malignant Mesothelioma 01/2020
1	Edema (Dropsy) 11/2018
1	Adenocarcinoma 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2012
1	Asthenia 03/2011
1	Fatigue 03/2011
1	Vomiting 03/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Solitary Pulmonary Nodule 02/2004
1	Hypoxia (Hypoxemia) 02/2004

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2005
3	durvalumabIBA 01/2022 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 06/2021 - 01/2016
3	HematinicsIBA 05/2008 - 01/2006
2	LigandsIBA 01/2022 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 06/2021 - 11/2018
2	Amylases FDA Link 01/2020 - 11/2018
2	Pemetrexed (MTA)FDA Link 01/2020 - 03/2011
2	ceritinibIBA 01/2020 - 10/2014
2	Lipase (Acid Lipase)FDA Link 01/2020 - 11/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2016
2	Hemoglobins (Hemoglobin)IBA 05/2008 - 04/2008
2	Glucose (Dextrose)FDA LinkGeneric 02/2004 - 07/2002
1	osimertinibIBA 06/2021
1	TabletsIBA 06/2021
1	B7-H1 AntigenIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	TransferasesIBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	NivolumabIBA 01/2020
1	FP-1039IBA 01/2020
1	Gefitinib (Iressa)FDA Link 11/2018
1	capmatinibIBA 11/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2016
1	Chimeric Antigen ReceptorsIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2015
1	NVP-BKM120IBA 09/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015
1	CrizotinibIBA 10/2014
1	Anaplastic Lymphoma KinaseIBA 10/2014
1	Gemcitabine FDA Link 01/2012
1	vandetanib (ZD6474)IBA 03/2011
1	Etoposide (VP 16)FDA LinkGeneric 05/2008
1	PlatinumIBA 05/2008
1	IronIBA 04/2008
1	Erythropoietin FDA Link 01/2006
1	Darbepoetin alfa (Aranesp)FDA Link 01/2006
1	Biological ProductsIBA 11/2004
1	technetium Tc 99m BTAP-annexin-VIBA 02/2004
1	Carrier Proteins (Binding Protein)IBA 02/2004
1	fluoromisonidazoleIBA 02/2004
1	EnzymesIBA 02/2004

Therapy/Procedure

9	Therapeutics 06/2021 - 02/2004
9	Drug Therapy (Chemotherapy) 01/2016 - 02/2004
3	Chemoradiotherapy 01/2022 - 01/2021
2	Immunotherapy 01/2018 - 01/2018
2	Adjuvant Chemotherapy 10/2015 - 02/2005
2	Radiotherapy 01/2006 - 02/2004
1	Precision Medicine 03/2016
1	Aftercare (After-Treatment) 05/2008